Follow us on:

Sativa Group take an important step forward with controlled drug licence

Sativa Group (NEX: SATI) CEO Henry Lees-Buckley joins DirectorsTalk to discuss the award of a Controlled Drug Licence from the UK Home Office. Henry explains why this is an important step forward for the company, what the licence enables the Sativa to do, what it means for the company and why this is such an important achievement.

Sativa Group PLC joined the NEX Exchange on 29th March 2018 as the first UK listed medicinal cannabis investment vehicle. Since then, the Company has changed its business strategy to capitalise on changes in the UK and European laws and regulations surrounding the cannabis industry.

Find more news, interviews, share price & company profile here for:Goodbody Health

Share this interview

Other Interviews

Sativa Wellness Group expect a significant ramp up (Interview) March 11, 2021
Sativa Wellness Group a true seed to consumer company (Interview) October 1, 2020
Sativa Group CEO Interview: How distributor alignments are now paying off February 21, 2020
Sativa Group ‘Adding serious horsepower to high street efforts’ November 26, 2019
CEO INTERVIEW: Why Sativa Group CEO Henry Lees-Buckley is confident of the future September 19, 2019
INTERVIEW: Sativa Group ‘A Big Boost’ from Health Secretary’s Statement July 16, 2019
INTERVIEW: Why Sativa Investments are making several changes May 10, 2019
INTERVIEW: Sativa Investments Flagship Store to Open in Bath May 3, 2019
INTERVIEW: Why Sativa Investments contract with Kings College London is an important step April 18, 2019
INTERVIEW: Sativa Investments – PhytoVista Market Leading in capability and turnaround times March 22, 2019

More News

Sativa Wellness Group CBD and cannabis regulatory progress December 14, 2020
Sativa Wellness expands COVID testing clinic in store to Bristol December 8, 2020
Sativa Wellness welcomes ECJ ruling on CBD November 24, 2020
Sativa Wellness Group a true seed to consumer company (Interview) October 1, 2020
Sativa Group joins the ACI toxicology study September 25, 2020
Sativa Group approved listing for Sativa Wellness Group on Canadian Securities Exchange September 10, 2020
Sativa Group receives Stillcanna shareholder approval for acquisition September 1, 2020
Sativa Group Plc and Stillcanna acquisition to go ahead August 18, 2020
Sativa Group delivers a record month of revenues August 11, 2020
Sativa Group launch a new Goodbody Wellness CBD and Vitamin D product range July 24, 2020

Search

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.